Navigation Links
Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
Date:1/17/2012

ALEXANDRIA, Va., Jan. 17, 2012 /PRNewswire/ -- Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced that it closed a $15 million round of debt financing with a leading provider of outsourced hospital services. The private equity backed company plans to use the funds for the recapitalization of its business.

"Oxford welcomes the opportunity to foster the growth of an outsourced hospital services provider that is backed by a strong equity sponsor," said Christopher A. Herr, managing director for Oxford Finance. "The company is well-managed and offers a service that enables hospitals to contain costs while improving patient care."

About Oxford Finance LLC

Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $1.5 billion in loans, with lines of credit ranging from $500 thousand to $50 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Illinois, Massachusetts and North Carolina. For more information visit www.oxfordfinance.com.

                 

 


'/>"/>
SOURCE Oxford Finance LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
2. Oxford BioMedica Announces US IND Approval for Novel Ocular Product in Usher Syndrome Type 1B
3. CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics
4. Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb
5. Oxford Finance Corporation Sponsors 2010 Mid-Atlantic Bio
6. Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio
7. Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
8. ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
9. Oxford BioTherapeutics Appoints Michael Moore as Chairman
10. Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films
11. TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2020)... , ... July 06, 2020 , ... R3 International is ... featuring up to 200 million stem cells. Depending on the patient's condition, treatment may ... the US will die having some form of Alzheimers dementia, and the incidence continues ...
(Date:7/1/2020)... , ... June 29, 2020 , ... ... to competitively procured purchasing contracts to its membership, recently named BioFit Engineered ... members with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and ...
(Date:6/28/2020)... SAN JOSE, Calif. (PRWEB) , ... June 25, ... ... the globe, researchers are racing to develop a vaccine or drug treatment. In ... company Recursion has publicly released the world’s largest imaging dataset portraying ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... lab-made bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System for ... of Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at ...
Breaking Biology Technology:
(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first in a ... the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles ... on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... B.V. (MBS) has announced a publication detailing the use of its revolutionary ... polymerase chain reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for biopharmaceutical R&D, today announced that it has entered into a multi-year ... antibodies (Multiclonics®), to support their translational and clinical research strategy to discover ...
Breaking Biology News(10 mins):